<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01521169</url>
  </required_header>
  <id_info>
    <org_study_id>NU332</org_study_id>
    <nct_id>NCT01521169</nct_id>
  </id_info>
  <brief_title>Long-term Effectiveness Study on Cholesterol-reducing Activity</brief_title>
  <official_title>Clinical Study for Evaluating the Plasma Cholesterol-reducing Activity of a Plant Sterol-enriched Yoghurt Drink - Effectiveness and Long-term Safety Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danone Japan</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Danone Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effect of consumption of a drinkable low fat
      fermented milk enriched with 0,8g or 1,6g of plant sterols on reducing plasma cholesterol
      (LDL-cholesterol) concentration during 12 weeks of product consumption.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">138</enrollment>
  <condition>Normal and Mild Hypercholesterolemic Subjects</condition>
  <arm_group>
    <arm_group_label>1 = Tested product dose 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2 = Tested product dose 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>3 = Control product</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>1 - low-fat dairy fermented product (drinkable) enriched with plant sterols (0,8g /day equivalent as free sterols).</intervention_name>
    <description>1 = Intervention with test product 1 (0,8g of plant sterol/day)</description>
    <arm_group_label>1 = Tested product dose 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>2 - low-fat dairy fermented product (drinkable) enriched with plant sterols (1,6g /day equivalent as free sterols).</intervention_name>
    <description>2 = Intervention with test product 2 (1,6g of plant sterol/day)</description>
    <arm_group_label>2 = Tested product dose 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>3 - low-fat dairy fermented product (drinkable) without plant sterols.</intervention_name>
    <description>3 = Intervention 3 (1 control product/day)</description>
    <arm_group_label>3 = Control product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject with total cholesterol plasma level between 200 mg/dL to 240 mg/dL; and
             LDL-cholesterol between 120 mg/dL to 160 mg/dL.

          2. Subject aged from 20 to 65 years (bounds included)

          3. Subject with BMI between 19 - 30 kg/m² (bounds included)

          4. Subject with triglycerides under 400 mg/dL (4.6 mmol/L)

          5. Non diabetic subjects (BS≤125 mg/dL)

          6. Non hypertensive subjects (SBP&lt;140mmHg and DBP&lt;90 mmHg)

          7. Subject accepting to follow the dietary recommendations advisable for
             hypercholesterolemic

          8. Subject agreeing not to consume any other plant sterol supplements or excess plant
             sterol during the study period

          9. Subject, upon briefing of the content of the present study, fully understanding and
             agreeing to its objective; and being able to personally sign a written informed
             consent and subject having signed the written consent to take part in the study

        Exclusion Criteria:

          1. Subject currently involved in a clinical trial.

          2. Subject taking any dislipademia treatment (statins,ezetimibe, niacin, omega-3 FA,
             fibrates)

          3. Subject having blood sample of 200 ml or more taken (e.g., donated blood) within 1
             month, or 400 ml or more within 3 months of the start of the present study.

          4. For female subject: pregnancy or intention to be pregnant during the study.

          5. For female subject: breast feeding.

          6. Subject presenting known allergy or history of hypersensitivity to plant sterols or
             dairy products.

          7. Subject having lactose intolerance.

          8. Subjects having sitosterolemia

          9. Diabetic subject (Type I and type II)

         10. Subject with heavy alcohol intake (&gt;60g/day)

         11. Subject receiving systemic treatment or topical treatment likely to interfere with
             evaluation of the study parameters

         12. Subject receiving a transplant or under immunosuppressor treatment

         13. Subject receiving treatment for serious liver, renal, cardio-vascular, respiratory,
             endocrine, or metabolic disorders.

         14. Subject having cardiovascular history or cardiovascular events (e.g.myocardial
             infarction, angina pectoris, surgical or endocoronary intervention, stroke, inferior
             member arteriopathy, etc.) during the last 6 months

         15. Subject deemed unsuitable by the investigator.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Senrichuo Ekimae Clinic - Senri Life Science Center 13F</name>
      <address>
        <city>Osaka</city>
        <zip>560-0082</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2012</study_first_submitted>
  <study_first_submitted_qc>January 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2012</study_first_posted>
  <last_update_submitted>October 26, 2016</last_update_submitted>
  <last_update_submitted_qc>October 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Plant sterol - Hypercholesterolemia - Diet - Dairy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

